An earlier study reported that the lp-PLA2 inhibitor, darapladib, reduces complex coronary atherosclerotic plaque development in pigs with induced diabetes and hypercholesterolemia [7]. The gene discussed is PLA2G7; the disease is diabetes mellitus.